All the news at a glance

Datwyler generated net revenue of CHF 582.7 million in the first half of 2026, up from CHF 563.0 million in the prior-year period, representing an organic growth of 4.6%. Division Healthcare continued its positive momentum, while Division Industrial remained affected by subdued end-markets and additional headwinds stemming from the conflict in the Middle East.

Datwyler welcomed Delaware Governor Matt Meyer today at its Middletown manufacturing facility, reinforcing the company’s commitment to healthcare manufacturing, innovation and workforce development in Delaware.

Datwyler announces changes to its Executive Board in order to strengthen its organization and set a clear course for the future.

Discover how self-lubricating elastomers compare with traditional greases and surface coatings, and why they offer operational and performance advantages in many applications.

The 68th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 17 March 2026. Share-holders approved all Board proposals by a large majority.

Self-lubricating elastomers are gaining attention as a material-based approach to reducing friction without additional greasing or surface treatments. This first article of a two-part series introduces the concept, explains how integrated lubrication works, and highlights the practical benefits for handling, performance, and consistency over time.

Datwyler has successfully completed the acquisition of a majority stake in Capsul’in as announced in December 2025.

In the 2025 financial year, Datwyler generated revenue of CHF 1'100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.

Datwyler announced a collaboration with LTS Device Technologies, a developer of smart wearable devices for drug delivery, and Stevanato Group

Datwyler has signed an agreement to acquire 51% of Capsul’Invest SA und Brain Corp SA (together operating as Capsul’in), a leading provider of aluminum coffee capsule solutions headquartered in Luxembourg with annual revenues of approximately EUR 90 million.

Wearables have become a major driver of innovation in personalized healthcare in recent years. Learn more about how we turn insights into solutions through our solution design approach on the example of SoftPulse® Flex

Datwyler gained momentum in the first half of 2025 despite a challenging environment.

Datwyler strengthens its market position and drives growth by commencing serial supply of premium components for GLP-1 therapies, reflecting its strategic investments and early-stage development partnerships within the rapidly expanding injectable drug market.

Datwyler's specialized sealing solutions ensure the efficient and reliable operation of electrolyzers and auxiliary systems.

Datwyler slightly increased its EBIT margin in 2024 despite weak markets and a slight decline in revenue. The transformation program «ForwardNow» will accelerate the planned profitable growth.

Datwyler is launching a transformation program for the period 2025 to 2027 to accelerate revenue and profitability growth.

Sealing influences the mechanical stability and thermal management of the battery, which is essential for maintaining optimal performance under various operating conditions.

Datwyler announces the expansion of its NeoFlex™ range of coated plungers with new sizes for containers aimed at large-volume auto-injectors and wearable devices.